3,433 Shares in CME Group Inc. $CME Purchased by Trust Investment Advisors

Trust Investment Advisors purchased a new position in shares of CME Group Inc. (NASDAQ:CME) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,433 shares of the financial services provider’s stock, valued at approximately $1,014,000.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of CME Group by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after buying an additional 588,509 shares in the last quarter. State Street Corp grew its stake in CME Group by 0.4% in the 4th quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after acquiring an additional 56,725 shares during the period. Norges Bank acquired a new stake in CME Group in the 4th quarter valued at $1,523,241,000. Bank of New York Mellon Corp increased its holdings in CME Group by 2.8% in the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after acquiring an additional 134,242 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after acquiring an additional 130,848 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Keefe, Bruyette & Woods upgraded CME Group (CME) to Outperform from Market Perform and kept a $305 price target, citing an attractive risk/reward setup after recent stock weakness. Article Title
• Positive Sentiment: Insider buying may also support sentiment: Director William Shepard bought 325 shares at about $230.57 per share, signaling confidence from management. Article Title
• Positive Sentiment: Analysts still expect modest earnings growth ahead of CME’s next report, and one note lifted FY2027 EPS estimates slightly, reinforcing the view that fundamentals remain solid. Article Title
• Neutral Sentiment: CME is expected to report second-quarter results soon, with Wall Street looking for low-single-digit profit growth; investors may be waiting for the print before making bigger moves. Article Title
• Negative Sentiment: Goldman Sachs cut its price target on CME Group (CME) to $245 from $267 and maintained a Sell rating, which likely weighed on the stock. Article Title
• Negative Sentiment: DraftKings’ move to bring its prediction-markets infrastructure in-house may reduce reliance on third-party platforms such as CME over time, creating a potential competitive headwind. Article Title

Insiders Place Their Bets

In related news, Director William R. Shepard bought 325 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Up 4.6%

Shares of NASDAQ CME opened at $231.00 on Thursday. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The stock has a market cap of $83.70 billion, a PE ratio of 19.71, a P/E/G ratio of 2.47 and a beta of 0.21. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a 50-day moving average of $269.11 and a 200 day moving average of $284.88.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the company posted $2.80 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were given a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.3%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. Barclays decreased their price objective on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Jefferies Financial Group lowered their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Weiss Ratings cut CME Group from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 25th. Finally, UBS Group restated an “overweight” rating on shares of CME Group in a research report on Monday, June 15th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $300.94.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.